Glycosylated Hemoglobin and Functional Decline in Community‐Dwelling Nursing Home–Eligible Elderly Adults with Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Objectives: To determine whether glycosylated hemoglobin (HbA1c) levels predict functional decline in older adults. Design: Longitudinal cohort study. Participants: Community‐dwelling, nursing home ( NH )‐eligible individuals with diabetes mellitus enrolled at On Lok between October 2002 and December 2008 (367 participants, 1,579 HbA1c measurements). Setting: On Lok Lifeways, the original model for Programs of All‐Inclusive Care for the Elderly. Measurements: The outcomes were functional decline or death at 2 years. The primary predictor was HbA1c. Age, sex, race and ethnicity, baseline function, comorbid conditions, length of time enrolled at On Lok, insulin use, and clustering of HbA1c within participants were adjusted for with mixed‐effects Poisson regression. Results: Mean age was 80, and 185 participants (50%) were taking insulin. Sixty‐three percent of participants experienced functional decline, and 75% experienced death or functional decline during the study period. At 2 years, higher HbA1c was associated with less functional decline or death ( P for trend = .006). Accounting for clustering and confounding factors, HbA1c of 8.0% to 8.9% was associated with a lower likelihood (relative risk = 0.88, 95% confidence interval = 0.79–0.99) of functional decline or death than HbA1c of 7.0% to 7.9%. Conclusion: In community‐dwelling, NH ‐eligible individuals with diabetes mellitus, HbA1c of 8.0% to 8.9% is associated with better functional outcomes at 2 years than HbA1c of 7.0% to 7.9%, suggesting that the current American Geriatrics Society guideline recommending a HbA1c target of 8.0% or less for older adults with limited life expectancy may be lower than necessary to maintain function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guidelines for improving the care of the older person with diabetes mellitus
California Healthcare Foundation/American Geriatrics Society, C. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.51.5s.1.x · Cited by 651 · cited 2×
“0% or lower may need to be revisited and possibly updated.(16) Glycemic control is a core element of diabetes mellitus care, and HbA1c has become the cornerstone measure of the quality of diabetes mellitus care.”
BackgroundIncidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas
Shorr, R. I. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440360095010 · Cited by 459
McWilliams, J. M., Meara, E., Zaslavsky, A. M., & Ayanian, J. Z. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-8-200904210-00005 · Cited by 315
Estimated benefits of glycemic control in microvascular complications in type 2 diabetes
Vijan, S., Hofer, T. P., & Hayward, R. A. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-9-199711010-00003 · Cited by 228 · cited 1×
“HbA1c was categorized because previous studies suggest that the relationship between HbA1c and outcomes may be nonlinear.(19) To characterize how HbA1c levels changed during follow-up, baseline HbA1c levels were compared with the last HbA1c measurement before 2-year follow-up or death.”
MethodWhat can we do to improve physical function in older persons with type 2 diabetes?
Caruso, L. B., Silliman, R. A., Demissie, S., Greenfield, S., & Wagner, E. H. (2000) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/55.7.m372 · Cited by 52
Cited by
Type 2 diabetes mellitus in older adults: clinical considerations and management
Bellary, S., Kyrou, I., Brown, J. E., & Bailey, C. J. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00512-2 · Cited by 639
Hypoglycemia in Older People - A Less Well Recognized Risk Factor for Frailty
Abdelhafiz, A. H., Rodríguez-Mañas, L., Morley, J. E., & Sinclair, A. J. (2015) · Aging and disease · doi:10.14336/ad.2014.0330 · Cited by 340
Frailty and sarcopenia - newly emerging and high impact complications of diabetes
Sinclair, A. J., Abdelhafiz, A. H., & Rodríguez-Mañas, L. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.05.003 · Cited by 276
Omura, T., & Araki, A. (2022) · Geriatrics & Gerontology International · doi:10.1111/ggi.14339 · Cited by 47
Heller, S. R., Pratley, R. E., Sinclair, A., Festa, A., Kiljański, J., Brusko, C. S., Duan, R., & Heine, R. J. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13051 · Cited by 18
Metadata
- Authors
- Yau, C. K., Eng, C., Cenzer, I. S., John Boscardin, W., Rice‐Trumble, K., & Lee, S. J.
- Venue
- Journal of the American Geriatrics Society
- Publisher
- Wiley
- Published
- 2012-06-15
- Volume
- 60
- Issue
- 7
- Pages
- 1215-1221
- ISSN
- 0002-8614 (ISSN-L)
- 1532-5415
- OpenAlex
- W2144465381
- Cited by
- 96
- References
- 5
- FWCI
- 7.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.